MIRM - Mirum Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

MIRM is currently covered by 8 analysts with an average price target of $66.72. This is a potential upside of $23.03 (52.71%) from yesterday's end of day stock price of $43.69.

Mirum Pharmaceuticals's activity chart (see below) currently has 62 price targets and 103 ratings on display. The stock rating distribution of MIRM is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 44.13% with an average time for these price targets to be met of 547.27 days.

Highest price target for MIRM is $68, Lowest price target is $39, average price target is $66.72.

Most recent stock forecast was given by DAVID LEBOWITZ from CITI on 13-Nov-2024. First documented stock forecast 12-Aug-2019.

Currently out of the existing stock ratings of MIRM, 58 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$68

$23.5 (52.81%)

$64

7 days ago
(13-Nov-2024)

3/5 (60%)

$24.61 (56.72%)

428

Buy

$66

$21.5 (48.31%)

$66

7 days ago
(13-Nov-2024)

1/28 (3.57%)

$22.61 (52.11%)

259

Buy

$50

$5.5 (12.36%)

$44

7 days ago
(13-Nov-2024)

6/7 (85.71%)

$6.61 (15.23%)

399

Buy

$49

$4.5 (10.11%)

$43

1 months 3 days ago
(17-Oct-2024)

6/10 (60%)

$9.68 (24.62%)

785

Buy

$60

$15.5 (34.83%)

$40

3 months 12 days ago
(08-Aug-2024)

3/7 (42.86%)

$20.13 (50.49%)

111

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is MIRM (Mirum Pharmaceuticals) average time for price targets to be met?

On average it took 547.27 days on average for the stock forecasts to be realized with a an average price target met ratio 44.13

Which analyst has the current highest performing score on MIRM (Mirum Pharmaceuticals) with a proven track record?

MANI FOROOHAR

Which analyst has the most public recommendations on MIRM (Mirum Pharmaceuticals)?

Mani Foroohar has 11 price targets and 9 ratings on MIRM

Which analyst is the currently most bullish on MIRM (Mirum Pharmaceuticals)?

Yasmeen Rahimi with highest potential upside - $32.5

Which analyst is the currently most reserved on MIRM (Mirum Pharmaceuticals)?

Jessica Fye with lowest potential downside - -$5.5

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?